NDC 17856-0120-2 - CaroSpir

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
17856-0120
Requested NDC
17856-0120-2
Package NDCs from labels
17856-0120-2, 17856-0120-1
Manufacturer
ATLANTIC BIOLOGICALS CORP.
Effective date
2024-04-12
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CaroSpir - ATLANTIC BIOLOGICALS CORP.ATLANTIC BIOLOGICALS CORP.2024-04-12HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
EffectiveRelated label
2024-04-12These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2024-01-30These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2022-03-11These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2022-01-28These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2020-05-20These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960
2020-01-31These highlights do not include all the information needed to use CAROSPIR ® safely and effectively. See full prescribing information for CAROSPIR ® . CAROSPIR ® (spironolactone) Oral Suspension, for oral use Initial U.S. Approval: 1960

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17856-0120-1CaroSpir72 in 1 BOXSuspension724
17856-0120-2CaroSpir2.5 mL in 1 CUPSuspension2.54

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17856-0120CAROSPIR SUSPENSION [ATLANTIC BIOLOGICALS CORP.]4Legacy NDC, 2 package rows20240415_07504afc-f0b6-40f6-8719-cd1c3e67fc35.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 71 · 1,403 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack11d06acd-1351-4afd-a16a-f035758e2a272026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
Huddle Barrier BalmGLYCERINBetter Barrier Co.5b3cf1ed-082b-15cf-e063-6394a90a688e2026-11-02WarningsExact identifier
unii: PDC6A3C0OX
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack2d0655d7-fda6-40c6-907c-acaba0e199872026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack10a5c989-66e3-494d-bfd8-b2d6df3be4112026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepackbb1423e8-1517-44c5-98e0-99be24ce269b2026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepack813d199a-9004-4102-8ade-cf877caedafb2026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
SPIRONOLACTONESPIRONOLACTONEBryant Ranch Prepackca194a2a-ed16-40f6-a78c-45c5f33921702026-11-02Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
Quality Choice Infants Dye Free Gas ReliefSIMETHICONECHAIN DRUG MARKETING ASSOCIATION6b8a1eaa-6f8c-4ab6-81e0-9d64f6f1b5e42026-10-30WarningsExact identifier
unii: 92RU3N3Y1O
Sodium Citrate and Citric AcidSODIUM CITRATE AND CITRIC ACID MONOHYDRATEPAI Holdings, LLC dba PAI Pharma63201a61-6ac5-41ae-8b2d-ff0d3a8ddfd52026-10-30Adverse reactionsExact identifier
unii: XF417D3PSL
Aveeno Baby Daily MoistureDIMETHICONEKenvue Brands LLCb34c8e71-7fad-484c-b387-3c424f50b7432026-10-30WarningsExact identifier
unii: 92RU3N3Y1O
Extra Strength Gas ReliefSIMETHICONESAFEWAYc8946bd2-6351-40e4-a139-d8214889bb4e2026-10-30WarningsExact identifier
unii: 92RU3N3Y1O
IMODIUM Multi-Symptom ReliefLOPERAMIDE HYDROCHLORIDE AND DIMETHICONEKenvue Brands LLCecb91e47-2b0c-47c8-9256-4623d8bc825e2026-10-29WarningsExact identifier
unii: 92RU3N3Y1O
ENCON EYEWASHEYEWASHEncon Safety Products, Inc.485c691e-f6a8-4836-e063-6294a90a16fc2026-10-29WarningsExact identifier
unii: 059QF0KO0R
QC Gas Relief Mint FlavorSIMETHICONEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)26b83259-744b-4711-a32f-9f8fe5d0555b2026-10-29WarningsExact identifier
unii: 92RU3N3Y1O
QUALITY CHOICE Nausea ReliefSODIUM CITRATE DIHYDRATEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)d89e41c1-399a-4157-8d54-bfefe3b1c1cd2026-10-28WarningsExact identifier
unii: B22547B95K
Quality Choice Infants Gas Relief Dye FreeSIMETHICONEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)841b85ef-2ac8-4dac-8659-cffb7e1b1e052026-10-28WarningsExact identifier
unii: 92RU3N3Y1O
gas reliefSIMETHICONEGLENMARK THERAPEUTICS INC., USA57f92baf-e15d-44a7-9924-a05cd5703ada2026-10-28WarningsExact identifier
unii: 92RU3N3Y1O
SPIRONOLACTONESPIRONOLACTONEREMEDYREPACK INC.860b08bf-c6c1-4310-8510-10b6779f3d592026-10-28Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
spironolactoneSPIRONOLACTONEREMEDYREPACK INC.39d82d50-0b77-4ef5-96b8-c1e05044a82c2026-10-28Warnings, Adverse reactionsExact identifier
unii: 27O7W4T232
gas reliefSIMETHICONEGLENMARK THERAPEUTICS INC., USA846c3c50-c513-4e00-86da-da145fadac0a2026-10-28WarningsExact identifier
unii: 92RU3N3Y1O

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.